These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28736738)

  • 41. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
    Parkin CG; Graham C; Smolskis J
    J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.
    Joubert M; Morera J; Vicente A; Rod A; Parienti JJ; Reznik Y
    J Diabetes Sci Technol; 2014 Sep; 8(5):1005-10. PubMed ID: 24876454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.
    Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW;
    Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes.
    Choe J; Won SH; Choe Y; Park SH; Lee YJ; Lee J; Lee YA; Lim HH; Yoo JH; Lee SY; Kim EY; Shin CH; Kim JH
    Diabetes Technol Ther; 2022 Mar; 24(3):201-211. PubMed ID: 34704794
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
    Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
    Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: A 2-year Swedish national survey of children and adolescents with type 1 diabetes.
    Wersäll JH; Adolfsson P; Forsander G; Hanas R
    Pediatr Diabetes; 2022 Nov; 23(7):1038-1044. PubMed ID: 35678764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry.
    Grammes J; Küstner E; Dapp A; Hummel M; Kämmer JC; Kubiak T; Schütz-Fuhrmann I; Zimny S; Bollow E; Holl RW;
    Diabet Med; 2020 May; 37(5):856-862. PubMed ID: 31853984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study using insulin pump therapy and continuous glucose monitoring in newly diagnosed very young children with type 1 diabetes: it is possible to bend the curve of HbA1c.
    Castorani V; Favalli V; Rigamonti A; Frontino G; Di Tonno R; Morotti E; Sandullo F; Scialabba F; Arrigoni F; Dionisi B; Foglino R; Morosini C; Olivieri G; Barera G; Meschi F; Bonfanti R
    Acta Diabetol; 2023 Dec; 60(12):1719-1726. PubMed ID: 37526745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HbA
    Evans-Cheung TC; Campbell F; Yong J; Parslow RC; Feltbower RG
    Diabet Med; 2019 Jan; 36(1):88-95. PubMed ID: 30059173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
    Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
    Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disordered eating behaviour in adolescents with type 1 diabetes on continuous subcutaneous insulin infusion; relation to body image, depression and glycemic control.
    Salah NY; Hashim MA; Abdeen MSE
    J Eat Disord; 2022 Apr; 10(1):46. PubMed ID: 35379350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.
    Thrailkill KM; Bunn RC; Uppuganti S; Ray P; Popescu I; Kalaitzoglou E; Fowlkes JL; Nyman JS
    Bone; 2020 Dec; 141():115625. PubMed ID: 32890778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multi-factorial analysis of bone morphology and fracture strength of rat femur in response to ovariectomy.
    Rosales Rocabado JM; Kaku M; Nozaki K; Ida T; Kitami M; Aoyagi Y; Uoshima K
    J Orthop Surg Res; 2018 Dec; 13(1):318. PubMed ID: 30545382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes.
    Zhang L; Leng X; Tian F; Xiao D; Xuan J; Yang H; Liu J; Chen Z
    Postgrad Med; 2022 Aug; 134(6):627-634. PubMed ID: 35695267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Viñals C; Quirós C; Giménez M; Conget I
    Diabetes Ther; 2019 Jun; 10(3):929-936. PubMed ID: 30900146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].
    Pańkowska E; Lipka M; Wysocka M; Szypowska A; Trippenbach-Dulska H; Czaplińska M; Kołodziejska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):11-5. PubMed ID: 12831632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.
    Matejko B; Cyganek K; Katra B; Galicka-Latala D; Grzanka M; Malecki MT; Klupa T
    Rev Diabet Stud; 2011; 8(2):254-8. PubMed ID: 22189548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.